v3.22.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities    
Net loss $ (188,466) $ (341,905)
Adjustments to reconcile net loss to net cash used in operating activities    
Fair value of shares issued for CRx Acquisition 223,255
Imputed interest on related party advances 2,250
Stock issued to officers and director 101,500 70,000
Amortization of discount on convertible debt - related 10,804 10,863
Amortization of discount on convertible debt 25,472
Changes is assets and liabilities    
(Increase) decrease in prepaids (360) 7,500
Increase in accounts payable and accrued expenses 893 188
Cash used in operating activities (47,907) (30,099)
Cash flows from investing activities    
Advance from officer   15,000
Cash used in investing activities 15,000
Cash flows from financing activities    
Cash provided by financing activities
Net increase in cash and cash equivalents (47,907) (15,099)
Cash and cash equivalents, beginning of period 116,898 18,041
Cash and cash equivalents, end of period $ 68,991 $ 2,942